News | Radiology Imaging | December 28, 2015 | Dave Fornell

Toshiba May Sell its Healthcare Division as Part of its Financial Reforms

Scandal following its announcement of intentionally posting false financial reports results in job cuts and putting its healthcare division up for sale

Toshiba May Sell its Healthcare Division as Part of its Financial Reforms

December 28, 2015 — Toshiba announced Dec. 21 it is considering selling off its healthcare division as part of its restructuring plans in the aftermath of its falsified financial reporting scandal from earlier this year. 

In February 2015, Toshiba revealed it had manipulated its financial figures for the past seven years to improve the image of its bottom line following the global economic downturn starting in 2008. In September Toshiba submitted amended financial reports from 2015 back to April 2009 to correct the misinformation on the previous reports. 

The Japanese Securities and Exchange Surveillance Commission imposed a penalty of 7.3 billion Yen (more than $60 million in U.S. dollars) due to the false financial statements. Toshiba also created an independent auditing group to investigate the financials, leading to the resignation of five members of the company’s Board of Directors.

The revelation of the false reporting statements has shown Toshiba to be in the red with some of its businesses. Its recent financial reports showed stagnation in its home appliance business, part of its lifestyles product and services divisions that include TVs and personal computers.  The division posted big revenue declines in 2015. 

During the Dec. 21 press conference, the company explained how it would revitalize itself in 2016. Beyond implementing financial reforms in its reporting, this includes cutting 10,600 jobs, mostly from its lifestyles and semiconductor divisions and from its corporate staff.  The company also prioritized selling shares of its healthcare segment to outside investors. The company said while the business has been profitable, it needs additional research and development, and management resources to continue its expansion.  The company said much of the R&D in this segment has been in creating next generation computed tomography (CT) systems

It is refocusing efforts in the energy and information storage divisions and is inviting outside majority shareholders in the healthcare business to secure management resources necessary for further growth. 

In its December financial report, Toshiba said its healthcare segment net sales grew to a total of $3.4 billion. The division's products include imaging systems for CT, MRI, PET-CT, angiography, digital X-ray, ultrasound and advanced visualization software.

Related Content

EchoGo Pro automates cardiac ultrasound measurements for heart functions, but also empower physicians to predict the occurrence of coronary artery disease (CAD).

EchoGo Pro automates cardiac ultrasound measurements for heart functions, but also empower physicians to predict the occurrence of coronary artery disease (CAD).

News | Cardiovascular Ultrasound | September 25, 2020
September 25, 2020 — Based on its recent analysis of the global...
An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Canon Medical Systems.

An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Canon Medical Systems.

News | Cardiac Imaging | September 25, 2020
September 25, 2020 — A study out of University Hospitals (UH) found that removing the cost barrier for coronary arter
RADLogics AI-Powered solution in use: chest X-ray of COVID-19 positive case with heatmap key image.

RADLogics AI-Powered solution in use: chest X-ray of COVID-19 positive case with heatmap key image.

News | Artificial Intelligence | September 23, 2020
September 23, 2020 — RADLogics
The cartilage in this MRI scan of a knee is colorized to show greater contrast between shades of gray.

The cartilage in this MRI scan of a knee is colorized to show greater contrast between shades of gray. Image courtesy of Kundu et al. (2020) PNAS

News | Artificial Intelligence | September 22, 2020
September 22, 2020 — Researchers at the University of Pitts...
New research from King's College London has found that COVID-19 may be diagnosed on the same emergency scans intended to diagnose stroke.

Canon Medical Systems

News | Cardiac Imaging | September 22, 2020
September 22, 2020 — New research from King's College London has
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”. We have been virtualizing various aspects of our lives for many years, but the circumstances of this one has moved almost all of our lives into the virtual realm.

Getty Images

Feature | Radiology Education | September 18, 2020 | By Jef Williams
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”.
Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer.

Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer. Contrast-enhanced CT (A), PET (B), and fused 18F-FDG PET/CT (C) images are displayed in comparison with contrast-enhanced T1-weighted MRI (D), PET, and fused 18F-FDG PET/MRI (F) images. In CT (A), hyperdense, subcentimeter liver lesion (arrows) in segment VII is suggestive of transient hepatic attenuation difference or small hemangioma. As malignancy cannot be excluded, it needs further investigation. On PET/MRI, lesion is clearly classified as metastasis because of contrast enhancement and tracer uptake due to later acquisition time point. Follow-up CT confirmed diagnosis after 78 d. Images created by Ole Martin, University Dusseldorf, Medical Faculty and Benedikt Schaarschmidt, University Hospital Essen.

News | PET-MRI | September 18, 2020
September 18, 2020 — A single-center observational study of more than 1,000 oncological examinations has demonstrated